Skip to main content
Kothari Fermanatation & Biochem Ltd logo

Kothari Fermanatation & Biochem Ltd — Investor Relations & Filings

Ticker · 507474 ISIN · INE991B01010 BSE.NS Manufacturing
Filings indexed 323 across all filing types
Latest filing 2019-05-21 Regulatory Filings
Country IN India
Listing BSE.NS 507474

About Kothari Fermanatation & Biochem Ltd

https://www.kothariyeast.in

Kothari Fermentation & Biochem Ltd specializes in the production of yeast and yeast-based derivatives through advanced fermentation technology. The company's primary product portfolio includes compressed yeast, dried yeast, and instant dry yeast, marketed under the brand name Sunrise. These products cater extensively to the bakery and food processing industries. Additionally, the firm operates in the biochemical sector, producing industrial alcohol, extra neutral alcohol, and rectified spirits. Utilizing integrated manufacturing processes, the company focuses on high-quality biochemical solutions for diverse industrial applications, including the beverage and pharmaceutical sectors. Its operations emphasize technical precision in fermentation to ensure product consistency and performance in commercial baking and industrial fermentation processes.

Recent filings

Filing Released Lang Actions
KOTHARI FERMENTATION & BIOCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve Pursuant to ....
Regulatory Filings
2019-05-21 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2019-04-29 English
We are hereby submitting the Compliance Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 issued by the practicing Company Secretary ....
Regulatory Filings
2019-04-23 English
Pursuant to regulation 7 (3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share ....
Regulatory Filings
2019-04-16 English
We are enclosing herewith Statement of Deviation or Variation in Public Issue, Rights Issue, Preferential Issue etc under Regulation 32(1) Of Securities and Exchange Board of India (Listing ....
Regulatory Filings
2019-04-10 English
This is to inform you that pursuant to the provisions of the Securities And Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's code of conduct ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Bombay Stock Exchange informing about the closure of the trading window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. It mentions the trading window closure period related to the declaration of audited financial results for the quarter and year ended March 31, 2019. The document is a regulatory announcement about trading restrictions and does not contain any financial statements or detailed report content. It is short (1583 characters) and serves as an official notification to the stock exchange. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2019-04-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.